Roxro Pharma
Roxro Pharma is a privately owned, virtual pharmaceutical company founded in 1999, focused on developing innovative treatments for pain management by identifying, licensing, and developing small-molecule compounds. The company aims to offer new therapeutic options by repurposing or further developing compounds that larger pharmaceutical firms deprioritize, with a mission to improve patient outcomes through accessible, non-invasive solutions. Their first product was an intranasal formulation of ketorolac, targeting non-opioid pain relief, especially post-surgical pain, and they continue to develop treatments for various diseases to enhance quality of life.
Industries
Nr. of Employees
small (1-50)
Roxro Pharma
6017 Snell Avenue, San Jose, CA 95123, United States
Products
Intranasal non‑opioid analgesic formulation
Route‑specific intranasal formulation of a non‑opioid analgesic developed to address acute and post‑surgical pain management.
circRNA RT‑PCR detection kit for major depressive disorder (IVD)
96‑test kit for detection of circular RNA biomarkers in saliva or plasma intended to support screening and classification of major depressive disorder; described as CE‑approved for IVD use.
Online marketplace for laboratory reagents and consumables
E‑commerce catalogue and sales channel for research reagents, consumables, solvents (including common bulk solvents), plasmids, vectors, cell culture materials, master mixes, and basic laboratory equipment for research use.
Intranasal non‑opioid analgesic formulation
Route‑specific intranasal formulation of a non‑opioid analgesic developed to address acute and post‑surgical pain management.
circRNA RT‑PCR detection kit for major depressive disorder (IVD)
96‑test kit for detection of circular RNA biomarkers in saliva or plasma intended to support screening and classification of major depressive disorder; described as CE‑approved for IVD use.
Online marketplace for laboratory reagents and consumables
E‑commerce catalogue and sales channel for research reagents, consumables, solvents (including common bulk solvents), plasmids, vectors, cell culture materials, master mixes, and basic laboratory equipment for research use.
Services
Entry‑level subscription providing project initiation and resource coordination for a limited number of projects without custom technical services.
Mid‑level subscription providing access to defined research modules, research support, and limited custom solutions.
Comprehensive subscription offering broad access to R&D modules, extended resource availability, and around‑the‑clock expert assistance.
Entry‑level subscription providing project initiation and resource coordination for a limited number of projects without custom technical services.
Mid‑level subscription providing access to defined research modules, research support, and limited custom solutions.
Comprehensive subscription offering broad access to R&D modules, extended resource availability, and around‑the‑clock expert assistance.
Expertise Areas
- Small‑molecule pain therapeutic discovery
- Drug repurposing and lifecycle extension
- Non‑invasive formulation development (intranasal)
- IVD development and CE marking
Key Technologies
- RT‑PCR / qPCR
- Digital PCR (ddPCR)
- Next‑generation sequencing (NGS)
- circRNA biomarker assays
News & Updates
An upcoming event focused on epigenetics and epigenomics.
A scientific article discussing the role of circular RNAs in depression and their potential as biomarkers and therapeutic targets.
An upcoming event focused on epigenetics and epigenomics.
A scientific article discussing the role of circular RNAs in depression and their potential as biomarkers and therapeutic targets.